DAPSONE 6% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC]

DAPSONE 6% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC]
PDF | XML

NDC 72934-1063-2
Set ID 8738e2b0-0b51-3a26-e053-2991aa0a1ade
Category HUMAN PRESCRIPTION DRUG LABEL
Packager Sincerus Florida, LLC
Generic Name
Product Class
Product Number
Application Number
  • Directions for use

    g

  • Sincerus Florida, LLC adverse reactions.

    d

  • Active, inactive

    d

  • NDC 72934-1063-2 DAPSONE 6 / NIACINAMIDE 4 Gel 30gm

    f

  • INGREDIENTS AND APPEARANCE
    DAPSONE 6% / NIACINAMIDE 4% 
    dapsone 6% / niacinamide 4% gel
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-1063
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DAPSONE (UNII: 8W5C518302) (DAPSONE - UNII:8W5C518302) DAPSONE6 g  in 100 g
    NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
    Product Characteristics
    ColorwhiteScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:72934-1063-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product05/01/2019
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other05/01/2019
    Labeler - Sincerus Florida, LLC (080105003)
    Establishment
    NameAddressID/FEIBusiness Operations
    Sincerus Florida, LLC080105003manufacture(72934-1063)

Related Drugs